Dr. David Horovitz, MD

Dr. Horovitz practices at Bakersfield Institute of Advanced Urology in Bakersfield, California.

Dr. Horovitz's NPI, 1013309947, was assigned on March 2, 2015. Dr. Horovitz graduated from University of Western Ontario in 2009. Dr. Horovitz holds California license A148088.

Dr. Horovitz's primary practice is Bakersfield Institute of Advanced Urology, at 3838 San Dimas St, Bakersfield, CA 93301 in Kern County. The practice phone is (661) 520-5010.

Dr. Horovitz's primary practice is Bakersfield Institute of Advanced Urology in Bakersfield, California. Dr. Horovitz is also affiliated with Dignity Health - Memorial Hospital. Dmand AI also links Dr. Horovitz to 1 more hospital, 1 physician office and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Horovitz practices, 4 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Horovitz's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Horovitz is board certified in urology by the American Board of Urology. Dmand AI has Dr. Horovitz's licenses on file in 2 states: California and New York.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease and prostate cancer among the conditions Dr. Horovitz treats.

CMS data shows 963 Medicare services from Dr. Horovitz across 12 procedure codes in 2024, for 317 Medicare patients. Medicare paid $105,194 for them.

CMS counts 317 Medicare patients who saw Dr. Horovitz in 2024. The largest group is 65 to 74, with 148 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 63% are also on Medicaid. Their average risk score is 1.68, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Horovitz's median patient age at 65, with 29% women.

In 2024, Dr. Horovitz wrote 871 Medicare Part D claims for 365 patients. 89% of them were for generic drugs. CMS names the drug for 788 of them, across 10 drugs with 11 or more claims each, at $70,980 in total drug cost. In 2023, CMS named 736 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Horovitz for performance year 2024, reported individually. Dr. Horovitz accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 9 papers to Dr. Horovitz, published from 2011 to 2017. 2017 was the busiest year, with 4. The most frequent topics are Prostatectomy, Prostatic Neoplasms and Robotic Surgical Procedures. Dr. Horovitz has published most often in BJU Int. Dr. Horovitz's most frequent co-authors are Girish S. Kulkarni, MD, PhD, Hani H. Rashid, MD and Vehniah Kristin Tjong, MD.

CMS Open Payments shows 162 general payments to Dr. Horovitz from 35 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 64% of the total. Coloplast Corp paid the most, $1,503.

Dr. Horovitz graduated from University of Western Ontario in 2009.

Dr. Horovitz is in network with 14 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 7. Check the plan with the practice before a visit.